Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pfizer Inc (PFE) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance

Pfizer IncTrade
TAKE-TWO INTERACTIVE SOFTWARE, INC Common StockTrade

Price performance (Past 24H)

Key statistics

Pfizer Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Pfizer Inc trades at $27.91 (market cap $158.39B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $211.48 (market cap $39.88B). The key difference: Pfizer Inc is far larger — about 4× TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock's market cap, and Pfizer Inc pays a 6.19% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals.

PFETTWO
Market Cap
$158.39B$39.88B
Volume
29,869,932
Sector
HealthMedia
52-Week High
$29.02$262.29
52-Week Low
$23.60$189.69
Enterprise Value
$209.89B$41.00B
Dividend Yield
6.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Pfizer Inc

Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.

Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.

TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Take-Two Interactive trades at $213.29, down 0.65% amid bearish technical signals despite strong analyst support. The stock shows negative profitability with a -4.79% net margin and -$4.48B net loss for 2025, though recent earnings beats and GTA 6's November launch anticipation provide catalysts. Cash flow improved to $457M net inflow in 2025 from prior deficits, while debt-to-asset ratio rose to 39.87%.

Outlook hinges on GTA 6's execution, with 79% analyst buy ratings and $302.60 price target suggesting 42% upside. Risks include high valuation multiples (P/S 5.91, EV/EBITDA 32.78) and reliance on single-title success. Near-term volatility may persist pending Q3 earnings and preorder trends.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE

About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.

Read more on TTWO